MSI-H CANCER
Clinical trials for MSI-H CANCER explained in plain language.
Never miss a new study
Get alerted when new MSI-H CANCER trials appear
Sign up with your email to follow new studies for MSI-H CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug MOMA-341 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug, MOMA-341, alone or with other treatments, in people with advanced solid tumors that have specific genetic markers (MSI-H or dMMR). The main goal is to check safety and find the best dose. About 132 adults whose cancer has not responde…
Matched conditions: MSI-H CANCER
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New daily pill aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental daily pill, NDI-219216, in about 134 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and see if it can shrink tumors. Participants will take the pill daily, visit the …
Matched conditions: MSI-H CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC